Haemonetics (HAE) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $126.48 +5.15%
Revenue Growth %: +5.6%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
ATS, SICP, FTCO, More
Revenue Growth %: +5.6%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q3 EPS of $0.48, $0.02 better than the analyst estimate of $0.46. Revenue for the quarter came in at $233.4 million versus the consensus estimate of $237.37 million.
Haemonetics reaffirmed FY2016 guidance.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Reservoir Media, Inc. (RSVR) Tops Q2 EPS by 2c; offers guidance
- VivoPower posts $6.8M revenue and $0.6M profit in Q1 FY2027
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
